PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 38 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19 | -20.8% | 11,184 | -7.6% | 0.00% | 0.0% |
Q2 2023 | $24 | -99.9% | 12,108 | -58.0% | 0.00% | -33.3% |
Q2 2022 | $31,000 | +93.8% | 28,816 | +89.6% | 0.00% | +200.0% |
Q1 2022 | $16,000 | +6.7% | 15,199 | -17.3% | 0.00% | -50.0% |
Q4 2021 | $15,000 | -87.9% | 18,371 | -33.8% | 0.00% | -77.8% |
Q1 2021 | $124,000 | – | 27,744 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |